Danger score versus ER volume
Danger score versus ER volume
According to CPSC NEISS 2005-2024, Aspirin Or Aspirin Compounds ranks #419 of 838 by danger score (35/100) at ER-volume #497 of 838 (1,274/yr). They are not the same ranking.
- #419
- danger rank of 838
- #497
- ER-volume rank of 838
- 35/100
- danger score
- 1,274/yr
- estimated ER visits (avg)
Danger score combines injury volume, hospitalization, fatality, and five-year trend. ER volume is the average annual NEISS estimate alone. Rank 1 is highest on each list.
Where this category's danger score sits nationally
Danger score (35/100) across 838 scored CPSC product categories
35 Lower than most lower than 50% of 838 product categories
scored CPSC product categories, bucketed by value
Each bar is a band; taller bars hold more product categories. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source CPSC NEISS, PlainSafety danger-score model · 2024
Composite verdict
Composite Safety Score: 49/100
One verdict blending 4 independently-sourced dimensions from two separate CPSC systems, each benchmarked against all 838 scored product categories by percentile rather than raw value, so no single huge-volume category can dominate the scale.
| Dimension | Value | National percentile | Weight applied | Source |
|---|---|---|---|---|
| Injury severity (hospitalization + fatality blend) | 10 | 77th | 35% | CPSC NEISS 20-year severity index |
| Annual ER injury volume | 1,274 | 37th | 30% | CPSC NEISS estimated annual ER-treated injuries |
| 5-year injury trend | -11% | 48th | 15% | CPSC NEISS 5-year % change in ER-treated injuries |
| Consumer incident reports | 1 | 18th | 20% | CPSC SaferProducts.gov public incident report count |
Methodology: each dimension is ranked against the full population's p10/p25/p50/p75/p90 breakpoints and interpolated to a 0-100 percentile; the composite is the weighted average of available percentiles. See methodology for the full benchmark table.
Where 25,478 estimated ER injuries land on the body
Body-part shares from the same CPSC NEISS injury_types extract for product code 1923. Segments sum to 25,478 - a body-map mix, not a danger score or ER-volume rank.
Two danger lenses
Same-group peer scores and this product's dial
The bars compare PlainSafety danger scores inside the Transportation & Substances group (same CPSC NEISS extract). The dial is this product's score alone on the Low/Moderate/High bands. Do not read a peer bar as an ER-visit count.
Transportation & Substances danger scores
How this 35/100 score is built
The score is computed from four CPSC-derived factors for aspirin or aspirin compounds - no opinion, no editorializing:
- Injury volume 1,274 ER visits/yr Below median volume
- Severity (hospitalization rate) 10.1% High admission rate
- Fatality rate 0.00% No recorded fatalities
- 5-year trend-11%
Band labels compare this category against the corpus of 838 scored CPSC product categories, see the full methodology for the exact weighting of each factor.
What the CPSC Data Shows
Across the 20-year NEISS window from 2005 to 2024, injury counts for aspirin or aspirin compounds are declining by about 11% over the last five years, with the busiest year on record being 2010 (2,182 estimated ER visits) and the quietest 2024 (801 estimated visits). The single most common ER diagnosis is poisoning to the all parts body, accounting for approximately 25,452 visits across the 20-year NEISS window, followed by burn, chemical to the eyeball (15 cases). The 0-4 age group absorbs the largest share of injuries, about 25,481 cases over the NEISS window, and males appear slightly more often than the opposite sex in that cohort. Severity outcomes from the NEISS disposition field show that 10.1% of ER visits involving this product end in hospital admission or transfer.
Beyond the hospital-sampled NEISS projections, this page also aggregates 1 consumer incident report filed directly on SaferProducts.gov, plus 20 anonymized ER narratives - together forming a layered picture of how aspirin or aspirin compounds fail in real households. Every figure on this page comes from CPSC-published data: NEISS projects national estimates from a probability sample of about 100 U.S. hospital emergency departments, while SaferProducts.gov collects voluntary reports from consumers, manufacturers, and clinicians. The danger score, trend indicators, and demographic breakdowns update automatically when CPSC releases a new yearly NEISS file, which is why this page is dated 2024-12-31. For regulatory context, consult CPSC recall notices and the SaferProducts.gov public database linked below.
Annual Injury Estimates (2005–2024)
Source: CPSC NEISS national estimates Injuries represent ER-treated cases only
Who Gets Injured?
| Age Group | Male | Female | Total |
|---|---|---|---|
| 0-4 | 13,429 | 12,052 |
Most Common Injuries
| Body Part | Diagnosis | Est. Injuries |
|---|---|---|
| All Parts Body | Poisoning | |
| Eyeball | Burn, Chemical | |
| Head | Internal Injury | |
| Lower Arm | Burn, Chemical |
Severity Breakdown
ER Visit Narratives
Real anonymized emergency room reports from the CPSC NEISS database.
4YOF CHILD DRANK NEARLY AN ENTIRE BOTTLE OF *** DX: ACCIDENTAL INGESTION OF SUBSTANCE
4 YOM OM FOR UNINTENTIONAL MEDICATION INGESTION APPROX. 2030 TODAY. MOM STATES PT FOUND WITH *** BOTTLE OPEN WITH MOST PILLS OUT, PT HAS CHEWED UP PILLS IN MOUTH. DX ACCIDENTAL ACETAMINOPHEN OVERDOSE, ASPIRIN OVERDOSE ACCIDENTAL, PAIN UPPER ABD
3YOM PRESENTS FOR A POSSIBLE INGESTION S/P PT'S MOTHER STATES SHE NOTICED THE PT WASN'T IN HER SIGHT. MOTHER WENT UPSTAIRS AND SAW THE PT IN HER ROOM PLAYING WITH A BOTTLE OF ASPIRIN. PT WAS PLAYING WITH THE SILICA GEL IN THE ASPIRIN BOTTLE. MOTHER ASKED PT IF HE SWALLOED ANY PILLS AND HE RESPONDED YES AND NO. MOTHER CALLED POISON CONTROL AND ADVISED THEM TO THE ED. DX: FEARED COMPLAINT WITHOUT DX
15MOF INGESTED AN UNKNOWN AMOUNT OF BABY ASPIRIN DX: SALICYLATE OVERDOSE
11 MOM WAS SITTING IN MOTHER'S LAP WATCHING TV, MOTHER LOOKED DOWN AND SAW PT WITH OPEN BOTTLE OF BABY ASPIRIN, MOTHER DID A MOUTH SWEEP AND FOUND ONE PILL INSIDE PT'S RIGHT CHEEK, DX: ASPIRIN POISONING, ACCIDENTAL INGESTION
19 MOM UNKNOWN AMOUNT INGESTION BABY ASA 81MG DX ACCIDENTAL DRUG INGESTION
3YOF GIVEN 1 81MG ASPIRIN ACCIDENTLY BY GRANDMOTHER. DX: NONE
3YOF PRESENTS AFTER SHE WAS FOUND WITH AN OPEN BOTTLE OF CHEWABLE ASPIRIN 81 MG AND THERE WAS ONE IN HER MOUTH. UNKNOWN HOW MANY SHE SWALLOWED. SALICYLATE LEVEL IS 3.3. DX: SALICYLATE OVERDOSE
11MOF PRESENTED TO ED C/O INGESTION OF FOREIGN SUBTANCE. PT INGESTED ASPRIN BOTTLE OF 81 MG AND VOMITED 3 TIMES. DX; INGESTION OF SUBSTANCE
2YOF WAS GIVEN 1/2 OF A BABY ASPIRIN BY GRANDMOTHER. PARENT CALLED PCP WHO TOLD THEM TO BRING CHILD TO ED. DX: ACUTE FEBRILE ILLNESS, ACCIDENTAL INGESTION OF SUBSTANCE
2YOM WAS FOUND WITH A *** BAG OF ASPIRIN AND *** PILL AT GRANDPARENT'S HOUSE. DX: ACCIDENTAL DRUG INGESTION.
22MOM WAS WITH SIBLING AND POSSIBLY INGESTED 81MG ASPIRIN FROM OPEN BOTTLE. DX: ACCIDENTAL DRUG INGESTION
Consumer Incident Reports
Reports filed by consumers on SaferProducts.gov.
25 month old child removed safety cap from bottle of Walgreens brand chewable aspirin. Consumed 30-32 pills.
Product Recalls
Search for active and past recalls related to aspirin or aspirin compounds on the CPSC website.
Compare beyond Transportation & Substances
Nationwide peers by danger score, ER volume & hospitalization
Three PlainSafety-derived comparison paths for Aspirin Or Aspirin Compounds: cross-group products nearest on danger score (35/100), estimated annual ER visits (1,274/yr), and hospitalization share (10.1%). Same-group neighbours stay in Related Products above.
Similar danger score
Nearest cross-group products by PlainSafety danger score (100-point scale).
Similar ER visit volume
Nearest cross-group products by NEISS estimated annual ER visits.
Similar hospitalization rate
Nearest cross-group products by % of NEISS ER visits resulting in hospital admission.
Related Products in Transportation & Substances
Read with this product
About this data
CPSC National Electronic Injury Surveillance System (NEISS) 2005–2024 and SaferProducts.gov consumer incident reports form the basis of this page. Injury estimates are based on a nationally representative probability sample of U.S. hospital emergency departments.
According to PlainSafety's CPSC NEISS corpus ranking, Aspirin Or Aspirin Compounds ranks #419 of 838 scored CPSC product categories by PlainSafety danger score and #497 of 838 by 20-year estimated ER injury volume.
Frequently Asked Questions
Where does aspirin or aspirin compounds rank on danger score versus ER volume?
Among 838 scored CPSC product categories, aspirin or aspirin compounds ranks #419 by PlainSafety danger score (35/100) and #497 by 20-year estimated ER injury volume (1,274/yr). The two rankings come from the same NEISS extract and are not the same order.
What are the most common injuries from aspirin or aspirin compounds?
The most common injury is poisoning to the all parts body, accounting for approximately 25,452 injuries over 20 years.
Are injuries from aspirin or aspirin compounds increasing or decreasing?
Down 11% over 5 years.
Who is most at risk for aspirin or aspirin compounds injuries?
The 0-4 age group accounts for the most injuries, with approximately 25,481 cases recorded over 20 years. Males are more frequently injured in this age group.
What happens when someone is injured by aspirin or aspirin compounds?
Of all ER visits involving aspirin or aspirin compounds, approximately 10.1% result in hospital admission. The majority of patients (89.9%) are treated and released from the emergency department.
How can I report a safety problem with aspirin or aspirin compounds?
You can file a consumer incident report at SaferProducts.gov, the official CPSC reporting portal. Reports help the CPSC identify emerging hazards and trigger investigations or recalls. You can also call the CPSC hotline at 1-800-638-2772.
PlainSafety is rendered directly from U.S. Consumer Product Safety Commission recall and incident records, no number is typed in by an editor. Product recall timelines and hazard labels are drawn from CPSC recall records for this product. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.